浮浮又沉沉
04-26
$信达生物(01801)$
信达生物IBI343拟纳入突破性治疗品种,针对适应症为至少接受过二种系统性治疗的Claudin(CLDN)18.2表达阳性的晚期胃/胃食管交界处腺癌。根据信达生物公开资料,IBI343是一款靶向Claudin18.2的抗体偶联药物(ADC)。目前该产品正在针对Claudin18.2阳性、HER2阴性胃癌开展3期临床研究。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":299530898391344,"tweetId":"299530898391344","gmtCreate":1714147182985,"gmtModify":1714147184993,"author":{"id":4129117073683340,"authorId":4129117073683340,"authorIdStr":"4129117073683340","name":"浮浮又沉沉","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/01801\">$信达生物(01801)$ </a>信达生物IBI343拟纳入突破性治疗品种,针对适应症为至少接受过二种系统性治疗的Claudin(CLDN)18.2表达阳性的晚期胃/胃食管交界处腺癌。根据信达生物公开资料,IBI343是一款靶向Claudin18.2的抗体偶联药物(ADC)。目前该产品正在针对Claudin18.2阳性、HER2阴性胃癌开展3期临床研究。\n<br></body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/01801\">$信达生物(01801)$ </a>信达生物IBI343拟纳入突破性治疗品种,针对适应症为至少接受过二种系统性治疗的Claudin(CLDN)18.2表达阳性的晚期胃/胃食管交界处腺癌。根据信达生物公开资料,IBI343是一款靶向Claudin18.2的抗体偶联药物(ADC)。目前该产品正在针对Claudin18.2阳性、HER2阴性胃癌开展3期临床研究。\n<br></body></html>","text":"$信达生物(01801)$ 信达生物IBI343拟纳入突破性治疗品种,针对适应症为至少接受过二种系统性治疗的Claudin(CLDN)18.2表达阳性的晚期胃/胃食管交界处腺癌。根据信达生物公开资料,IBI343是一款靶向Claudin18.2的抗体偶联药物(ADC)。目前该产品正在针对Claudin18.2阳性、HER2阴性胃癌开展3期临床研究。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/299530898391344","repostId":0,"isVote":1,"tweetType":1,"viewCount":295,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01801"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":271,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/299530898391344"}
精彩评论